These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22731728)

  • 1. Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.
    Glotfelty LG; Hecht GA
    Ann N Y Acad Sci; 2012 Jul; 1258():149-58. PubMed ID: 22731728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.
    Glotfelty LG; Zahs A; Hodges K; Shan K; Alto NM; Hecht GA
    Cell Microbiol; 2014 Dec; 16(12):1767-83. PubMed ID: 24948117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability.
    Matsuzawa T; Kuwae A; Abe A
    Infect Immun; 2005 Oct; 73(10):6283-9. PubMed ID: 16177299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli.
    Smollett K; Shaw RK; Garmendia J; Knutton S; Frankel G
    Microbes Infect; 2006 Jul; 8(8):2220-7. PubMed ID: 16781180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier.
    Tomson FL; Viswanathan VK; Kanack KJ; Kanteti RP; Straub KV; Menet M; Kaper JB; Hecht G
    Mol Microbiol; 2005 Apr; 56(2):447-64. PubMed ID: 15813736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells.
    Shaw RK; Smollett K; Cleary J; Garmendia J; Straatman-Iwanowska A; Frankel G; Knutton S
    Infect Immun; 2005 Jul; 73(7):4385-90. PubMed ID: 15972534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector.
    Dean P; Mühlen S; Quitard S; Kenny B
    Cell Microbiol; 2010 Sep; 12(9):1308-21. PubMed ID: 20345487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal proline-rich repeats of Enteropathogenic E. coli effector EspF are sufficient for the depletion of tight junction membrane proteins and interactions with early and recycling endosomes.
    Ansari I; Mandal A; Kansal K; Walling P; Khan S; Aijaz S
    Gut Pathog; 2024 Jul; 16(1):36. PubMed ID: 38972985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli.
    Tomson FL; Koutsouris A; Viswanathan VK; Turner JR; Savkovic SD; Hecht G
    Gastroenterology; 2004 Sep; 127(3):859-69. PubMed ID: 15362041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.
    Clements A; Smollett K; Lee SF; Hartland EL; Lowe M; Frankel G
    Cell Microbiol; 2011 Sep; 13(9):1429-39. PubMed ID: 21740499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.
    Germane KL; Spiller BW
    Biochemistry; 2011 Feb; 50(6):917-9. PubMed ID: 21235237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.
    Singh AP; Aijaz S
    Bioengineered; 2015; 6(6):335-41. PubMed ID: 26430918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tight junction barrier function by outer membrane proteins of enteropathogenic Escherichia coli: role of F-actin and junctional adhesion molecule-1.
    Puthenedam M; Williams PH; Lakshmi BS; Balakrishnan A
    Cell Biol Int; 2007 Aug; 31(8):836-44. PubMed ID: 17382565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.